Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Therapeutic aspects of cannabis and cannabinoids.
Characterizations of reflex and nonreflex changes in spastic multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
The top clinical trial opportunities in therapeutic apheresis and neurology.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Monomethylfumarate reduces in vitro migration of mononuclear cells.
Targeting IL-10 in Auto-immune Diseases.
The essential role of t cells in multiple sclerosis: A reappraisal.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Pregnancy and multiple sclerosis.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
MS as a gateway disease.
Pages
« first
‹ previous
…
378
379
380
381
382
383
384
385
386
…
next ›
last »